CD34+ Humanized Mice
Human cord blood-derived hematopoietic CD34+ stem cells. Validated: greater than 25% human CD45+ cells in peripheral blood. Humanized NSG variants (hu-CD34+). Infectious disease, gene therapy, cancer,
Watch Video
Learn. Engage. Connect.
Human cord blood-derived hematopoietic CD34+ stem cells. Validated: greater than 25% human CD45+ cells in peripheral blood. Humanized NSG variants (hu-CD34+). Infectious disease, gene therapy, cancer,
Watch Video
Assessing efficacy and toxicity in CAR-T studies in an accessible translational model. The Jackson Laboratory's in vivo PBMC-humanized mouse platform provides a wider window to look at cytokine releas
Watch Video
In this special joint webinar, we discuss CAR T-induced Immunotoxicity, highlighting cutting-edge platforms for assessing the safety and efficacy of CAR therapies and preventing the development of CRS
Watch Video
Read Flipbook
Read Flipbook
Learn how mouse models help researchers disentangle the complexity of rare disease and help drive preclinical drug development.
Learn More
Learn the benefits of using the FcRn mouse model platform in characterizing the PK of your therapeutic, from the long half-life to the types of antibody therapeutics that can be screened.
Watch Video
Read Flipbook
Read Flipbook
Read Flipbook
Read Flipbook
Brian Soper, Ph.D. presents preclinical data demonstrating: Monoclonal antibody-based human immune modulation, donor-specific differences in bispecific antibody-mediated tumor efficacy and cytokine re
Watch Video
Join us in person or virtually for JAX's signature cancer training program, August 14 – 22, 2023.
Learn More
Read Flipbook
Read Flipbook
Read Flipbook
Read Flipbook
Read Flipbook
Read Flipbook
Read Flipbook
Loading More...